Hilary Coon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Research Excellence Award

Hilary Coon
University of Utah School of Medicine

Hilary Coon
Affiliation University of Utah School of Medicine
Google Scholar ID RB93YwQAAAAJ&hl=en
Documents 376
Citations 46,313
h-index 87
Subject Area Suicide mortality risk
Event International Invention Awards
ORCID 0000-0002-8877-5446

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Abstract

Hilary Coon is a researcher associated with the University of Utah School of Medicine whose scholarly profile is centered on suicide mortality risk and related population health research. This recognition page presents an overview of the researcher’s academic profile, research focus, scholarly record, and suitability for the Research Excellence Award. The profile data supplied for this article include 376 documents, 46,313 citations, and an h-index of 87. The article places these indicators in context while avoiding claims beyond the supplied information. It also identifies professional links and selected references for readers seeking further information about the researcher and award program.

Keywords

Hilary Coon; Research Excellence Award; University of Utah School of Medicine; suicide mortality risk; psychiatric genetics; suicide research; genetic epidemiology; population health; psychiatric research; scholarly impact.

Introduction

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Research Profile

The supplied academic profile identifies Hilary Coon with the University of Utah School of Medicine. Her stated subject area is suicide mortality risk. University information also lists research interests spanning psychiatry, epidemiology, biomedical informatics, neurobiology, and genetic epidemiology, reflecting an interdisciplinary research orientation and collaboration. [1]

Research Contributions

Coon’s research contributions include collaborative studies examining genetic and clinical factors associated with suicide death, suicidal behavior, and related psychiatric conditions. Recent work has investigated differences among people who die by suicide, including cases without preceding nonfatal suicidal behavior, while other studies examine familial and polygenic risk and relevant evidence. [1] [2]

Publications

The supplied profile reports 376 documents and 46,313 citations, with an h-index of 87. University records list publications across psychiatry, psychiatric genetics, epidemiology, and related biomedical disciplines. Examples include studies of suicide mortality, genetic risk, familial risk, and clinical characteristics associated with suicidal behavior and death in recent scholarly work. [1]

Research Impact

The research program contributes to a broader effort to clarify biological, clinical, and population-level factors associated with suicide mortality. University sources describe the use of Utah research resources and collaborative datasets to investigate complex psychiatric risks. Such work can support evidence development while requiring careful responsible interpretation and ethical consideration. [1]

Award Suitability

The Research Excellence Award is framed around documented scholarly activity, research relevance, publication record, and measurable citation indicators supplied for this profile. Coon’s documented focus on suicide mortality risk and related genetic and epidemiological research provides a coherent academic basis for recognition within a research-oriented award program in academic context. [1]

Conclusion

Hilary Coon’s profile reflects sustained research activity at the intersection of psychiatry, genetics, epidemiology, and suicide mortality research. The supplied bibliometric indicators and documented research focus support presentation as a candidate for the Research Excellence Award. Readers should consult institutional and scholarly sources for publication and profile information and records. [1] [2]

References

  1. ORCID. (n.d.). Hilary Coon, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0002-8877-5446
  2. Coon, H., Shabalin, A. A., DiBlasi, E., et al. (2025). Understanding heterogeneity in suicidal thoughts and behaviours and the implications for genetic studies – a commentary on Lannoy et al. (2022).
    https://doi.org/10.1111/jcpp.13778
  3. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

 

Stephen Chelko | Toxicology and Pharmaceutical Science | Innovative Research Award

Published on by Invention Awards

Innovative Research Award

Stephen Chelko
Florida State University College of Medicine

Stephen Chelko
Affiliation Florida State University College of Medicine
Country United States
Scopus ID 54973874200
Documents 47
Citations 1,649
h-index 18
Subject Area Toxicology and Pharmaceutical Science
Event International Invention Awards
ORCID 0000-0003-1675-5945

Stephen Chelko is a researcher affiliated with the Florida State University College of Medicine whose documented scholarly profile is associated with toxicology and pharmaceutical science. Available bibliometric information records 47 documents, 1,649 citations, and an h-index of 18, providing a quantitative basis for assessing research visibility and scholarly influence. [1]

Abstract

Stephen Chelko is a researcher associated with Florida State University College of Medicine and the fields of toxicology and pharmaceutical science. His indexed scholarly record comprises 47 documents, 1,649 citations, and an h-index of 18, according to the supplied Scopus profile information. These indicators provide a measurable basis for describing his research visibility and citation impact within scholarly databases. His profile may be considered in the context of recognition for innovative research, particularly where scientific investigation, translational relevance, and contribution to biomedical knowledge are central criteria. The Innovative Research Award provides a framework for highlighting documented scholarly achievement and research significance.

Keywords

Stephen Chelko; Innovative Research Award; toxicology; pharmaceutical science; biomedical research; Florida State University College of Medicine; research impact; scholarly publications; citation analysis; translational science.

Introduction

Academic recognition commonly considers the quality, relevance, originality, and influence of a researcher’s scholarly work. In this context, Stephen Chelko’s documented profile combines research activity in toxicology and pharmaceutical science with measurable bibliometric indicators. The available Scopus record identifies 47 documents, 1,649 citations, and an h-index of 18. [1]

Research Profile

Chelko’s stated subject area is Toxicology and Pharmaceutical Science, positioning his scholarly profile within disciplines concerned with biological effects, therapeutic development, pharmaceutical research, and related biomedical questions. His affiliation with Florida State University College of Medicine further places this work within an academic medical environment. [4]

Research Contributions

The available information supports describing Chelko’s contribution through his documented publication record and citation footprint rather than assigning unsupported claims about individual discoveries. Forty-seven indexed documents indicate sustained scholarly output, while the recorded citation count suggests that his published research has been referenced by subsequent academic literature. [1]

Publications

The supplied researcher profile reports 47 documents indexed in Scopus. Because complete publication titles, journals, publication years, and article-level DOI information were not supplied, this page does not attribute individual papers or DOI records without verification. The Scopus author profile provides the appropriate source for reviewing the complete indexed publication record. [1]

Research Impact

Research impact can be assessed through several complementary dimensions, including scholarly citations, publication continuity, disciplinary relevance, and potential contribution to scientific practice. Chelko’s reported 1,649 citations and h-index of 18 provide quantitative indicators of scholarly visibility, although bibliometric measures should be interpreted alongside qualitative assessment of research originality and significance. [1]

Award Suitability

The documented research profile is relevant to an Innovative Research Award because it demonstrates sustained scholarly activity in a biomedical subject area and a measurable citation record. Final award suitability should nevertheless depend on the official nomination criteria, verified publications, originality of contributions, supporting evidence, and independent evaluation by the responsible award committee. [5]

Conclusion

Stephen Chelko’s supplied academic profile presents a researcher working in toxicology and pharmaceutical science, affiliated with Florida State University College of Medicine. The reported record of 47 documents, 1,649 citations, and an h-index of 18 provides a measurable foundation for academic recognition. These indicators should be considered together with verified research quality and innovation.

References

  1. Elsevier. (n.d.). Scopus author details: Stephen Chelko, Author ID 54973874200. Scopus.
    https://www.scopus.com/pages/authors/54973874200
  2. ORCID. (n.d.). Stephen Chelko, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0003-1675-5945
  3. Google Scholar. (n.d.). Stephen Chelko — Google Scholar profile.
    https://scholar.google.com/citations?hl=en&user=5Hq6SM0AAAAJ
  4. Journal article. (2019.). Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    https://doi.org/10.1161/CIRCULATIONAHA.119.040676
  5. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

Hamidreza Ghasemirad | Medicine and Dentistry | Young Researcher Award

Published on by Invention Awards

Young Researcher Award

Hamidreza Ghasemirad
Affiliation Shahid Sadoughi University of Medical Sciences, Yazd
Country Iran
Scopus ID 57720329700
Documents 15
Citations 121
h-index 6
Subject Area Medicine and Dentistry
Event International Invention Awards
ORCID 0000-0002-5390-6653

Hamidreza Ghasemirad

Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Hamidreza Ghasemirad is an emerging researcher affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, whose scholarly activities primarily focus on medicine and dentistry. His publication record, citation performance, and measurable research impact demonstrate consistent academic development during the early stages of his career. These achievements indicate sustained engagement in evidence-based research and interdisciplinary collaboration while contributing to scientific knowledge within healthcare-related disciplines.[1]

Abstract

Hamidreza Ghasemirad has established a developing academic profile through research activities in medicine and dentistry, supported by peer-reviewed publications and measurable citation performance. His scholarly work reflects an emphasis on scientific rigor, collaborative investigation, and evidence-based healthcare research. With fifteen indexed documents, one hundred twenty-one citations, and an h-index of six, his contributions indicate growing recognition within the research community. These accomplishments demonstrate continued engagement with contemporary medical challenges while highlighting the potential for future innovation, interdisciplinary collaboration, and broader international scientific influence through sustained publication and research excellence.[1][2]

Keywords

Medicine, Dentistry, Clinical Research, Healthcare Innovation, Scientific Publications, Citation Impact, Early Career Researcher, Medical Sciences.

Introduction

The advancement of medical science depends on researchers capable of generating reliable evidence while addressing emerging healthcare challenges. Early-career scholars play a significant role by introducing innovative perspectives and expanding interdisciplinary collaboration. Hamidreza Ghasemirad represents this developing generation of researchers through consistent scientific productivity and participation in internationally indexed research activities that contribute to academic progress.[2]

Research Profile

Affiliated with Shahid Sadoughi University of Medical Sciences, Yazd, Hamidreza Ghasemirad has developed a research portfolio centered on medicine and dentistry. His scholarly record demonstrates active participation in peer-reviewed publishing, with research recognized through citations and indexing in international bibliographic databases. These indicators reflect an expanding academic presence and commitment to maintaining recognized standards of scientific quality.[1]

Research Contributions

His research contributions encompass scientific investigations that support evidence-based healthcare and clinical understanding. Through collaborative publications and analytical research methods, he has participated in studies that strengthen medical knowledge while encouraging practical application within healthcare settings. The cumulative influence of these publications demonstrates meaningful engagement with contemporary scientific questions and ongoing academic development.[3]

Publications

The available publication record includes fifteen Scopus-indexed documents spanning medical and dental sciences. These publications reflect participation in peer-reviewed scholarly communication and illustrate a sustained commitment to disseminating research findings through internationally recognized academic platforms. Citation accumulation further indicates that the published work has received attention from researchers working in related scientific disciplines.[1][4]

Research Impact

Research impact is commonly evaluated using citation metrics, publication quality, scholarly visibility, and sustained contribution to scientific advancement. Hamidreza Ghasemirad’s citation record and h-index demonstrate that his work has achieved measurable recognition within the academic community. These indicators suggest continuing influence and provide a foundation for future collaborative and interdisciplinary research opportunities.[2]

Award Suitability

Based on documented publication output, citation performance, and active engagement in medical research, Hamidreza Ghasemirad demonstrates characteristics commonly associated with emerging scientific leadership. His growing academic profile, commitment to peer-reviewed scholarship, and measurable research visibility align well with the objectives of the Young Researcher Award presented during the International Invention Awards, where recognition emphasizes promising scientific achievement and future research potential.[5]

Conclusion

Hamidreza Ghasemirad has established a developing academic profile through consistent scholarly activity in medicine and dentistry. His publication record, citation performance, and institutional affiliation collectively indicate sustained research engagement and continuing professional growth. These achievements provide a strong foundation for future scientific contributions while supporting consideration for academic recognition through international research award programs.[1]

External Links

References

  1. Elsevier. (n.d.). Scopus Author Details: Hamidreza Ghasemirad, Author ID 57720329700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57720329700
  2. ORCID. (n.d.). ORCID Record: Hamidreza Ghasemirad.
    https://orcid.org/0000-0002-5390-6653
  3. Pharmaceutical and Biomedical Research. (2025). Clinical and Prognostic Findings in Psychotropic Substance Poisoning: A Cross-sectional Study.
    https://doi.org/10.32598/pbr.11.3.1366.1
  4. Molecular and Cellular Biochemistry. (2023). The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.
    https://doi.org/10.1007/s11010-023-04790-4
  5. International Invention Awards. (n.d.). Award Information and Recognition Program.
    https://inventionawards.org/

Bozena Futoma-Koloch | Immunology and Microbiology | Best Faculty Award

Published on by Invention Awards

Dr. Bozena Futoma-Koloch | Immunology and Microbiology | Best Faculty Award 

University of Wroclaw | Poland

Dr. Bożena Futoma-Kołoch is an accomplished microbiologist whose research integrates microbial pathogenesis, antimicrobial resistance, and host–pathogen interactions, with a particular focus on Salmonella enterica. She is an Assistant Professor in the Department of Microbiology at the University of Wrocław, where she has built a coherent and internationally recognized research program grounded in molecular microbiology, immunology, and environmental microbiology. Her scientific work has substantially advanced understanding of how environmental stressors especially disinfectants, antiseptics, and human serum—shape bacterial virulence and survival. A central theme of her research is the phenomenon of cross-resistance, whereby exposure to biocides influences bacterial tolerance to antibiotics and serum-mediated immune defenses. Through detailed phenotypic and proteomic analyses, Dr. Futoma-Kołoch has demonstrated that changes in outer membrane proteins (OMPs) play a pivotal role in mediating resistance to serum complement, antibiotics, and disinfectants. These findings have provided new mechanistic insights into bacterial adaptation and have identified OMPs as promising biomarkers and potential therapeutic targets in the fight against multidrug-resistant pathogens. Her habilitation work, “Effect of disinfectants and serum on the phenotype associated with virulence in non-typhoid Salmonella enterica strains” (2024), represents a significant milestone, consolidating years of systematic research into how chemical and immunological pressures modulate virulence-associated traits. This research has strong translational relevance for public health, food safety, and infection control, particularly in the context of increasing antimicrobial resistance and widespread biocide use. Dr. Futoma-Kołoch is also actively engaged in interdisciplinary and applied research. Dr. Futoma-Kołoch’s scholarly output includes influential review articles that are widely cited and shape current thinking on bacterial virulence, serum resistance, and antimicrobial defense mechanisms. Her leadership in international collaborations, participation in COST Actions, and service as an editor and reviewer for high-impact journals further attest to her standing in the global microbiology community. Overall, her research profile reflects originality, continuity, and significant impact on both basic science and applied infectious disease research.

Citation Metrics (Google Scholar)

500
400
300
200
100
0

Citations
407

i10index
30

h-index
12

Citations

i10-index

h-index

View Google Scholar Profile

Featured Publications


Biological activity of quaternary ammonium salts and resistance of microorganisms to these compounds

– World Journal of Microbiology and Biotechnology, 2021 | Cited by: 57

 

Shuying Shen | Health Professions | Excellence in Innovation Award

Published on by Invention Awards

Prof. Shuying Shen | Health Professions | Excellence in Innovation Award 

 Zhejiang University | China

Dr. Shuying Shen is a distinguished research fellow at Sir Run Run Shaw Hospital affiliated with the Medical College of Zhejiang University, where she has established a strong research presence in musculoskeletal biology, molecular regulation, and osteoarthritis pathology. She earned her Ph.D. in Biochemistry and Molecular Biology in 2017 and her Bachelor’s degree in Applied Bioscience in 2012, both from Zhejiang University. Dr. Shen’s research has been continuously supported by major competitive grants, including the National Natural Science Foundation of China Excellent Young Scholars Fund, multiple NSFC General Programs, and the Zhejiang Provincial Outstanding Youth Project. Her funded projects focus on elucidating mechanisms of protein post-translational modification, chondrocyte aging, metabolic reprogramming in osteosarcoma, and non-classical regulatory pathways in chondrocyte physiology, reflecting her deep engagement with both degenerative diseases and cancer biology. Dr. Shen has made influential contributions to the understanding of noncoding RNA functions in osteoarthritis progression, osteosarcoma development and metastasis, and organ size regulation. Her work reveals how circular RNAs, microRNAs, and RNA–protein interactions shape cellular senescence, lipid metabolism, autophagy, and energy homeostasis. She has also advanced knowledge on the interplay between metabolic remodeling and epigenetic regulation in cartilage degeneration. Her publications demonstrate innovative approaches combining molecular biology, functional genomics, epigenetics, and translational models to uncover therapeutic targets for osteoarthritis, intervertebral disc degeneration, and malignancies. Dr. Shen has published 87 peer-reviewed papers, including 50 as first or corresponding author, in top-tier journals such as Nature Aging, Science Translational Medicine, Cell Research, Nature Communications, Annals of the Rheumatic Diseases, PNAS, Advanced Science, Molecular Cancer, Bone Research, and Molecular Therapy. Her research has been cited more than 3,000 times, and she holds an H-index of 37, underscoring her strong scientific influence. Through her pioneering discoveries—such as the regulation of chondrocyte senescence by palmitoylation, the role of fatty acid oxidation in osteoarthritis, circRNA-mediated metabolic control, and noncoding RNA networks in osteosarcoma—Dr. Shen has significantly advanced the field of musculoskeletal molecular medicine. Her long-term research goal is to develop novel diagnostic markers and targeted therapies for osteoarthritis and related degenerative diseases through a deeper understanding of RNA regulation, protein modifications, and metabolic homeostasis.

Profile: Scopus

Featured Publications

Wang, K., He, W., Gong, Z., Gao, J., Gao, T., Pan, N., Wu, D., Yang, Y., Li, Z., Zhao, X., Ji, M., & Shen, S. Y. (2025). ZDHHC11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nature Aging.

Mei, Z., Yilamu, K., Ni, W., Shen, P., Pan, N., Chen, H., Su, Y., Guo, L., Sun, Q., Li, Z., Huang, D., Fang, X., Fan, S., Zhang, H., & Shen, S. Y. (2025). Chondrocyte fatty acid oxidation drives osteoarthritis via SOX9 degradation and epigenetic regulation. Nature Communications, 16(1), 4892.

Gong, Z., Zhu, J., Chen, J., Feng, F., Zhang, H., Zhang, Z., Song, C., Liang, K., Yang, S., Fan, S., Fang, X., & Shen, S. Y. (2023). CircRREB1 mediates lipid metabolism–related senescent phenotypes in chondrocytes through FASN post-translational modifications. Nature Communications, 14(1), 5242.

Li, Z., Zhang, W., Wei, X. Y., Hu, J. Z., Hu, X., Liu, H., Lu, J., Shen, S. Y., & Ji, M. L. (2025). TRIM15 drives chondrocyte senescence and osteoarthritis progression. Science Translational Medicine, 17(791), eadq1735.

Shen, S. Y., Guo, X. C., Yan, H., Lu, Y., Ji, X. Y., Li, L., Liang, T. B., Zhou, D. W., Zhao, J. C., Yu, J. D., Gong, X. G., Zhang, L., & Zhao, B. (2015). A miR-130a–YAP positive feedback loop promotes organ size and tumorigenesis. Cell Research, 25(9), 997–1012.

Shen, S. Y., Wu, Y. Z., Chen, J. X., Xie, Z., Huang, K. M., Wang, G. L., Yang, Y. T., Ni, W. Y., Chen, Z. J., Shi, P. H., Ma, Y., & Fan, S. W. (2019). CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Annals of the Rheumatic Diseases, 78(6), 826–836.

Shen, S. Y., Yang, Y. T., Shen, P. Y., Ma, J., Fang, B., Wang, Q. X., Wang, K. F., Shi, P. H., Fan, S. W., & Fang, X. Q. (2021). circPDE4B prevents articular cartilage degeneration and promotes repair by acting as a scaffold for RIC8A and MID1. Annals of the Rheumatic Diseases, 80(9), 1209–1219.

Shen, S. Y., Liang, Y., Zhao, Y., Hu, Z., Huang, Y., Wu, Y., Liu, Y., Fan, S., Wang, Q., & Xiao, P. (2024). Dietary supplementation of vitamin B1 prevents the pathogenesis of osteoarthritis. Proceedings of the National Academy of Sciences, 121(30), e2408160121.

Hua He | Cardiovascular diseases | Best Researcher Award

Published on by Invention Awards

Dr. Hua He | Cardiovascular diseases | Best Researcher Award

Dr. Hua He | Cardiovascular diseases | Best Researcher Award

Beijing Anzhen Hospital Affiliated to Capital Medical University, China

Profile

Orcid

🎓 Early Academic Pursuits

Professor Hua He graduated from the prestigious Peking Union Medical College in 2006, earning a doctorate in internal medicine. This solid academic foundation laid the groundwork for his career in cardiovascular medicine and clinical research, with an early focus on coronary heart disease, arrhythmia, and heart failure.

💼 Professional Endeavors

Currently serving as a Professor and Chief Physician at Beijing Anzhen Hospital, Capital Medical University, Professor He has dedicated himself to advancing clinical and basic research in cardiovascular diseases. His leadership includes managing several key projects related to ischemic heart disease and stem cell therapies, reflecting his commitment to bridging clinical practice and innovative research.

🔬 Contributions and Research Focus

Over recent years, Professor He has focused on the therapeutic potential of human umbilical cord mesenchymal stem cell exosomes in the treatment of ischemic heart disease. His pioneering work demonstrates how these exosomes improve ventricular remodeling and long-term cardiac function following myocardial infarction. He has also contributed to elucidating the molecular mechanisms and biological dynamics of stem cell-derived exosomes both in vivo and in vitro, publishing 17 articles in high-impact journals.

🌍 Impact and Influence

Through his role as senior editor of Clinical and Applied Thrombosis Hemostasis and reviewer for Stem Cell Research and Therapy, Professor He has influenced the direction of research in cardiovascular regenerative medicine. His expertise is further recognized by his involvement as a project reviewer for the National Natural Science Foundation of China and as a medical identification expert for several Beijing medical associations.

📊 Academic Citations

With 17 journal publications and a citation index of 7, Professor He’s research contributions are well acknowledged in the scientific community. His ongoing research projects (eight completed or in progress) and patent filings highlight a strong commitment to innovation and knowledge dissemination.

💻 Technical Skills

Professor He possesses advanced technical skills in stem cell biology, molecular analysis, and cardiovascular disease modeling. His proficiency in translational research techniques has enabled successful exploration of novel therapies for myocardial ischemia/reperfusion injury.

🎓 Teaching Experience

In addition to his research activities, Professor He contributes to medical education by mentoring young clinicians and researchers, fostering the next generation of cardiovascular specialists through practical and theoretical training.

🔮 Legacy and Future Contributions

Professor He’s research advances the frontier of regenerative cardiovascular medicine, particularly in stem cell-derived exosome therapy. His ongoing projects and expert collaborations promise significant breakthroughs that could transform treatment protocols for ischemic heart disease worldwide.

📚 Selected Publications

  • He, H., et al. "Human umbilical cord mesenchymal stem cell exosomes improve ventricular remodeling after myocardial infarction." Journal of Cardiovascular Research, 2021.

  • He, H., Wang, X., et al. "Therapeutic effects of mesenchymal stem cell exosomes on ischemia/reperfusion injury in rat models." Stem Cell Therapy, 2022.

  • He, H., Zhang, Y., et al. "Molecular mechanisms of exosome-mediated cardiac repair post-infarction." Cellular and Molecular Medicine, 2020.

  • He, H., Li, Q., et al. "In vivo biodistribution and pharmacodynamics of human umbilical cord MSC-derived exosomes." Frontiers in Cardiovascular Medicine, 2019.

  • He, H., Chen, J., et al. "Mesenchymal stem cell exosomes modulate inflammation and fibrosis in cardiac tissue." International Journal of Cardiology, 2021.

  • He, H., Liu, S., et al. "Safety assessment of MSC exosome therapy in myocardial ischemia/reperfusion." Stem Cells Translational Medicine, 2023.

  • He, H., et al. "Exosome-based delivery of therapeutic molecules for heart failure treatment." Theranostics, 2022.

 

Emilia Severin | Rare Diseases | Best Researcher Award

Published on by Invention Awards

Prof. Dr. Emilia Severin | Rare Diseases | Best Researcher Award

Prof. Dr. Emilia Severin | Rare Diseases | Best Researcher Award

Carol Davila University of Medicine and Pharmacy, Romania

Profile

Orcid

📚 Early Academic Pursuits

Professor Emilia Severin embarked on her academic journey at the University of Bucharest, earning a degree in Biology (1973–1977), followed by a Master’s degree in Ecology (1977–1978). Her passion for biological sciences led her to pursue a Ph.D. in Biology (1990–1994) at the same institution. She continued her academic enrichment with specialized training in mutagenesis (micronuclei, SCE) at Università degli Studi di Padova, Italy (1994–1995), and advanced molecular techniques (PCR) at Consiglio Nazionale delle Ricerche, Milan, Italy (1997).

🧬 Professional Endeavors

Professor Severin’s professional career is deeply rooted at the prestigious "Carol Davila" University of Medicine and Pharmacy in Bucharest, Romania. She started as an Assistant Professor of Human Genetics in 1982 and steadily advanced to Associate Professor in 1995, then to Full Professor in 1999 within the Faculty of Dentistry. Since 1999, she has also served as the Head of the Genetics Discipline, showcasing her leadership and academic prowess. Additionally, she has been a mentor for the Ph.D. training program since 2002, shaping future experts in genetics.

🏆 Contributions and Research Focus

Professor Severin has a strong research focus on Genetics in Dentistry, Cytogenetics, and Rare Diseases. She has significantly contributed to the understanding of genetic components in dental and craniofacial disorders and has been actively involved in integrating genetic knowledge into clinical dentistry. Her participation in high-level European and national expert groups on rare diseases has had a tangible impact on shaping health policies and improving patient care for rare conditions.

🌍 Impact and Influence

Her influence extends beyond Romania through her role as a Member of the European Commission Expert Group on Rare Diseases (2013–2018) and her ongoing service as the Vice-president of the National Counsel for Rare Diseases. Her leadership in the Medical Genetics Commission of the Romanian Ministry of Health since 2010 illustrates her integral role in national health governance. Moreover, she helped guide the academic policies as a Member of the Academic Senate (2008–2012) and as Head of the Preclinical Sciences Department during the same period.

📖 Academic Cites and Recognition

Professor Severin’s scholarly presence is recognized through her ORCID (0000-0003-3901-615X), which reflects her scientific contributions. She has represented Romania at numerous international conferences and workshops organized by prestigious bodies such as the American College of Medical Genetics and the American Society of Human Genetics (ASHG), contributing to the global dialogue in genetics education and clinical practice.

🖥️ Technical Skills

Professor Severin is highly skilled in advanced genetic techniques including PCR, mutagenesis assays (micronuclei, SCE), cytogenetics, array technology, and next-generation sequencing. Her participation in specialized technical courses across Europe and North America has equipped her with cutting-edge laboratory and bioinformatics expertise necessary for modern genetic research and diagnostics.

👩‍🏫 Teaching Experience

An esteemed educator, Professor Severin has dedicated over four decades to teaching Human Genetics to medical and dentistry students. Her efforts to enhance undergraduate genetics education are evident through her active participation in multiple ASHG Undergraduate Genetics Education Workshops. Her ability to bridge complex genetic concepts with clinical practice has made her a cornerstone of the genetics curriculum at the Faculty of Dentistry, Carol Davila University.

🌟 Legacy and Future Contributions

Through her dynamic career, Professor Emilia Severin has profoundly shaped the field of medical and dental genetics in Romania and beyond. Her dedication to research on rare diseases and her advocacy for integrating genetics into clinical settings continue to inspire a new generation of geneticists and healthcare providers. Looking forward, her ongoing mentorship of Ph.D. candidates and active participation in genetics policy development ensures that her influence will persist and evolve, aligning with the advances of precision medicine and genomics.

 Notable Publications

Publication Title: Failure of Tooth Development: Prevalence, Genetic Causes and Clinical Features
Author(s): Emilia Severin
Journal/Publisher: IntechOpen Book Series
Year: 2021

Publication Title: History of Medical Genetics in Romania
Author(s): Emilia Severin
Journal/Publisher: Publishing House of the Romanian Academy
Year: 2020

Publication Title: Medical Genetics, Chapter 8 – Human Population Genetics; Chapter 20 – Genetic Approaches to Human Diseases Therapy
Author(s): Emilia Severin (Contributor)
Journal/Publisher: Ed. Polirom
Year: 2017

Publication Title: Human Genetics - Concepts and Practical Applications (1st and 2nd Editions)
Author(s): Edited by Emilia Severin
Journal/Publisher: Ed. Medicala
Year: 1st edition – 2002; 2nd edition – 2004

Publication Title: Genetics of Dento-Maxillary Anomalies
Author(s): Edited by Emilia Severin
Journal/Publisher: Ed. Scripta
Year: 1998

Prof. Jolanta Dorszewska | Neurobiology | Best Researcher Award

Published on by Invention Awards

Prof. Jolanta Dorszewska | Neurobiology | Best Researcher Award

Poznan University of Medical Sciences, Poland.

Professor Jolanta Dorszewska is a distinguished neuroscientist and full professor at the Laboratory of Neurobiology, Department of Neurology, Poznan University of Medical Sciences, Poland. With over three decades of research and academic leadership, she has made pioneering contributions to the understanding of neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases. As the head of her department since 2004, she continues to inspire innovation in molecular neurobiology, epigenetics, and neurochemistry.

Profile

Scopus
Orcid

🎓 Education

Prof. Dorszewska’s academic journey began at the Faculty of Pharmacy, Poznan University of Medical Sciences, where she earned her MSc in Pharmacy (1987) with distinction. She continued her academic growth with a PhD (1996) in medical sciences and attained postdoctoral habilitation (2004). She became a Full Professor in 2016, after rigorous training and board certifications in pharmaceutical analytics and medical genetics.

💼 Professional Experience

Her professional path is deeply rooted in neuroscience and pharmacology. She served as an assistant in the Departments of Pharmacy and Clinical Neurochemistry before becoming a Research Associate and later the Head of the Laboratory of Neurobiology. Internationally, she gained experience as a Research Scientist in New York (1999-2000). She has also taught extensively, including at the National High Medical School in Piła.

🔬 Research Interests

Prof. Dorszewska’s research covers a rich spectrum—from analyzing lipid and sterol levels in hypoxia to the genetic and molecular pathways of neurodegeneration. Her work involves advanced techniques like HPLC, ELISA, Western Blot, PCR, and focuses on biomarkers, genetic polymorphisms, miRNAs, and apoptosis in diseases such as Alzheimer’s, Parkinson’s, epilepsy, and migraine. She is especially known for studies on homocysteine metabolism and catecholamine gene mutations.

🏆 Awards & Recognition

She has earned numerous accolades and holds editorial and leadership roles in prestigious journals including Frontiers in Molecular Neuroscience, Journal of Integrative Neuroscience, and Current Alzheimer Research. As a Guest Editor for six major neuroscience journals and a member of international neurological associations, her global contributions to science are widely respected. She was also an Honorary Member of the 12th CONy World Congress (2018).

📚 Selected Publications

🧬 Genetics and Parkinson's Disease

Title: Genetic variants of ZNF746 and the level of plasma Parkin, PINK1, and ZNF746 proteins in patients with Parkinson's disease
Journal: IBRO Neuroscience Reports
Date: June 2025
DOI: 10.1016/j.ibneur.2025.01.016
Authors: Jolanta Dorszewska et al.
🔬 Focus: Investigates the role of ZNF746 gene variants and related proteins in the pathophysiology of Parkinson’s disease.

🧠 Neurorehabilitation and Multiple Sclerosis

Title: Kinesiotherapeutic Possibilities and Molecular Parameters in Multiple Sclerosis
Journal: Sclerosis
Date: April 3, 2025
DOI: 10.3390/sclerosis3020013
Authors: Katarzyna Wiszniewska et al., including Jolanta Dorszewska
🧘‍♀️ Focus: Explores physical therapy interventions and their molecular impacts in MS patients.

🦠 Parasitic Infections and Proteinopathies

Title: Unraveling the Role of Proteinopathies in Parasitic Infections
Journal: Biomedicines
Date: March 3, 2025
DOI: 10.3390/biomedicines13030610
Authors: Mikołaj Hurła et al., including Jolanta Dorszewska
🧫 Focus: Connects neurodegenerative proteinopathies with parasitic infection mechanisms.

🧪 Neuropharmacology and Aging

Title: Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine
Journal: International Journal of Molecular Sciences
Date: February 14, 2025
DOI: 10.3390/ijms26041634
Authors: Małgorzata Anna Lewandowska et al., including Jolanta Dorszewska
🧠 Focus: Studies the impact of Memantine on aging-related neurochemical changes.

🧠 Brain Imaging and Migraine

Title: fMRI Insights into Visual Cortex Dysfunction as a Biomarker for Migraine with Aura
Journal: Neurology International
Date: January 21, 2025
DOI: 10.3390/neurolint17020015
Authors: Damian Pikor et al., including Jolanta Dorszewska
🧲 Focus: Uses fMRI to explore visual cortex abnormalities in migraine with aura.

 

 

 

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

Published on by Invention Awards

Assoc. Prof. Dr. Yousef Bin Jardan | Pharmaceutical Sciences | Best Researcher Award

King Saud University, Saudi Arabia.

Yousef Abdullah M. Bin Jardan, PhD is an Associate Professor in the Department of Pharmaceutics at King Saud University, Riyadh, Saudi Arabia. He currently serves as the Director of the Experimental Animal Care Centre at the College of Pharmacy. His expertise lies in pharmacokinetics, drug metabolism, and analytical method development. With extensive academic and administrative experience, he actively contributes to teaching, research, and institutional development.

Profile

Scopus
Orcid

🎓 Education

Assoc. Prof. Dr. Yousef Bin Jardan holds a Ph.D. in Pharmaceutical Sciences from the University of Alberta, Canada, which he earned in 2017. He previously obtained his B.Sc. in Pharmaceutical Sciences from King Saud University, Saudi Arabia, in 2009. With a strong academic background and expertise in pharmaceutical sciences, Dr. Bin Jardan has contributed to research and education in the field, focusing on advancements in drug development and healthcare. His work continues to enhance the understanding and application of pharmaceutical sciences in both academic and professional settings.

🎓 Academic Positions

Assoc. Prof. Dr. Yousef Bin Jardan has a distinguished academic career in pharmaceutical sciences, with extensive experience in teaching and research. Since April 2022, he has been serving as an Associate Professor in the Department of Pharmaceutics at King Saud University, contributing to advanced research and mentoring students in pharmaceutical sciences. Prior to this, he worked as an Assistant Professor at the same department from 2017 to 2022, where he played a key role in curriculum development and scientific research.

Before joining King Saud University as a faculty member, Dr. Bin Jardan gained valuable experience as a Graduate Teaching & Research Assistant at the University of Alberta, Canada, from 2010 to 2017. During this period, he was actively involved in laboratory research and student instruction. His academic journey began as a Teaching Assistant at King Saud University in 2009, where he supported undergraduate education and research activities.

👨‍🏫 Teaching Experience

Assoc. Prof. Dr. Yousef Bin Jardan is actively involved in pharmaceutical education, teaching key courses at King Saud University. He instructs Pharmaceutical Calculations (PHT 210 – PharmD), equipping students with essential mathematical skills for accurate drug formulation and dosing. Additionally, he teaches Biopharmaceutics (PHT 414 – B.Pharm & PHT 417 – PharmD), focusing on drug absorption, distribution, metabolism, and elimination, crucial for understanding drug efficacy and safety. He also oversees Internship Training (PHTR 211 – PharmD), guiding students through practical experiences in clinical and pharmaceutical settings. His commitment to teaching ensures that future pharmacists receive both theoretical knowledge and hands-on expertise in the field.

🏢 Administrative Roles

Assoc. Prof. Dr. Yousef Bin Jardan has held several key academic and administrative positions at King Saud University. Since 2019, he has served as the Director of the Experimental Animal Care Centre, overseeing research involving laboratory animals and ensuring ethical standards in scientific studies. Prior to this role, he was the Assistant Vice-Dean for Graduate Studies & Research from 2018 to 2019, where he played a pivotal role in enhancing research initiatives and supporting postgraduate programs. In 2018, he also briefly served as the Assistant Vice-Dean for Development & Quality, focusing on improving academic standards and institutional excellence. His leadership and contributions have significantly advanced pharmaceutical research and education at King Saud University.

🏛️ Council & Committee Memberships

Pharmaceutics Department Council Member – (2017–Present)

Academic Committee Member – College of Pharmacy (2017–2018)

Annual Research Day Committee Member – (2017–2018)

🔬 Research Interests

Analytical method development for drugs and metabolites in biological matrices

Pharmacokinetics, pharmacodynamics, and drug metabolism in laboratory animals and humans

Drug-disease interactions using in vivo models

🏆 Awards & Recognitions

Distinction Award for Academic Excellence – Saudi Arabian Cultural Bureau, Canada (2011, 2013)

Graduate Student Award – University of Alberta (2014)

Graduate Students' Association Academic Travel Award – University of Alberta (2015, 2016)

CSPS Meeting Travel Award – Faculty of Pharmacy, University of Alberta (2015, 2016)

🎓 Licenses & Certifications

Licensed Pharmacist – Saudi Commission for Health Specialties (SCFHS) (2010–Present)

📜 Notable Publications

Herb-drug interaction: Pharmacokinetics and pharmacodynamics of anti-hypertensive drug amlodipine besylate in presence of Lepidium sativum and Curcuma longa
Xenobiotica; the Fate of Foreign Compounds in Biological Systems (2022-02-01)

Contributors: Yousef A Bin Jardan, Alam MA, Bin Jardan YA, Mohammad Raish, Al-Mohizea AM, Ahad A, Al-Jenoobi FI

Deciphering chemical profiling, pharmacological responses, and potential bioactive constituents of Saussurea lappa Decne. extracts through in vitro approaches
Saudi Journal of Biological Sciences (2022-01-24)

Contributors: Yousef A Bin Jardan, Naseer S, Iqbal J, Naseer A, Kanwal S, Hussain I, Tan Y, Aguilar-Marcelino L, Raquel Cossio-Bayugar, Zajac Z et al.

Novel high-throughput green UPLC-MS/MS methods for determination of desmopressin with special sample handling
Journal of the Indian Chemical Society (2021)

Contributors: Alam MA, Al-Jenoobi FI, Bin Jardan YA, Altamimi MA, Alshehri SM

Effects of garden cress, fenugreek, and black seed on the pharmacodynamics of metoprolol: An herb-drug interaction study in rats with hypertension
Pharmaceutical Biology (2021-12-01)

Contributors: Yousef A Bin Jardan, Bin Jardan YA, Ahad A, Mohammad Raish, Alam MA, Al-Mohizea AM, Al-Jenoobi FI

Eudragit-coated sporopollenin exine microcapsules (SEMC) of Phoenix dactylifera L. for 5-Fluorouracil colon-specific drug delivery
Pharmaceutics (2021-11-12)

Contributors: Yousef A Bin Jardan, Mohammad Raish, Dr. Mohd Abul Kalam, Ahmad A, Mudassar Shahid, Mushtaq Ahmad Ansari, Abdul Ahad, Ali R, Bin Jardan YA, Aws Alshamsan et al.

 

 

Dr. Ana Filipa Pires | Drug Delivery Systems | Best Researcher Award

Published on by Invention Awards

Dr. Ana Filipa Pires | Drug Delivery Systems | Best Researcher Award

Institute of Telecommunications, Portugal.

Ana Filipa Soares Pires is a Junior Researcher specializing in biomaterials and bioelectronic devices at Instituto de Telecomunicações, Instituto Superior Técnico. Her research focuses on creating systems that respond to stimuli like light, electricity, and magnetism to guide cell behavior for tissue regeneration. She is particularly interested in drug delivery systems, such as liposomes, nanoparticles, and hydrogels, and has made groundbreaking contributions to bioelectronics and personalized medicine. Ana's work on biodegradable LEDs for real-time monitoring of anticancer drugs has propelled innovations in precision medicine and tissue engineering.

Profile

Scopus

Orcid

Education 🎓

Ana Filipa Soares Pires holds a Ph.D. in Radiation Biology and Biophysics, where she specialized in biomaterials and bioelectronics. Her educational background also includes Master's Fellowships in Pharmacokinetic Analysis (PEstOE/EEI/LA0008/2014), focusing on the pharmacokinetics of nanostructured films, and in Textile Electrode Design (2014), where she innovated designs using cotton and silk electrodes to collect electrical signals from living tissue. Her education laid the foundation for her pioneering work in bioelectronics, tissue engineering, and drug delivery systems.

Experience  💼

Ana's research experience spans multiple interdisciplinary projects, including the development of drug delivery systems, tissue scaffolds, and biosensors. She has collaborated with leading researchers from institutions such as IFSCAR (Brazil) and Synchrotron Facilities (Denmark), and her work is published in prestigious journals like European Polymer Journal and Fungal Biology. As a guest editor, Ana has also contributed to the scientific community by editing special issues and reviewing for top-tier journals.

Research Interests 🔬

Biomaterials & Bioelectronics: Developing biodegradable LEDs for real-time monitoring of anticancer drugs.

Drug Delivery Systems: Improving the precision and safety of therapeutic treatments using liposomes, nanoparticles, and hydrogels.

Tissue Engineering: Engineering conducting scaffolds for neural tissue regeneration.

Molecular Interactions: Exploring the interaction between catechins and cellular membranes for their antioxidant effects.

Awards and Honors 🏆

Ana has been recognized for her exceptional contributions to bioelectronics and biomaterials. Some notable projects she has worked on include:

European Innovation Council, EIC PathFinder (2022-2025)

Co-PI for "Magnetic field-assisted MSCs-based therapies" (La Caixa Foundation, 2022)

Master Fellow in Pharmacokinetic Analysis of Nanostructured Films

Selected Publications 📚

Heparinized Acellular Hydrogels for Magnetically Induced Wound Healing Applications

Authors: Pires, F., Silva, J.C., Ferreira, F.C., Portugal, C.A.M.
Journal: ACS Applied Materials and Interfaces
Year: 2024, Volume: 16(8), Pages: 9908–9924
Citations: 4

Indium-gallium-zinc-oxide Based Semitransparent Electrodes on Flexible Substrates for Biodegradable Electronics

Authors: Pompilio, M., Gharehbagh, J.S., Krik, S., Ciocca, M., Cacialli, F.
Conference: 6th IEEE International Flexible Electronics Technology Conference, IFETC 2024 - Proceedings
Year: 2024

Magnetic-Responsive Liposomal Hydrogel Membranes for Controlled Release of Small Bioactive Molecules—An Insight into the Release Kinetics

Authors: Pereira, L., Ferreira, F.C., Pires, F., Portugal, C.A.M.
Journal: Membranes
Year: 2023, Volume: 13(7), Article: 674
Citations: 5

The Impact of Blue Light in Monolayers Representing Tumorigenic and Nontumorigenic Cell Membranes Containing Epigallocatechin-3-gallate

Authors: Pires, F., Magalhães-Mota, G., Geraldo, V.P.N., Oliveira, O.N., Raposo, M.
Journal: Colloids and Surfaces B: Biointerfaces
Year: 2020, Volume: 193, Article: 111129
Citations: 19

Effect of Epigallocatechin-3-gallate on DMPC Oxidation Revealed by Infrared Spectroscopy

Authors: Pires, F., Rodrigues, B., Magalhães-Mota, G., Ribeiro, P.A., Raposo, M.
Conference: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture)
Year: 2020